Trial Profile
Phase I/II trial of Carboplatin plus Pemetrexed in elderly patients with advanced non squamous non small cell lung cancer
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 07 Jun 2016
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary) ; Carboplatin
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 31 May 2016 Status changed from recruiting to completed.
- 03 Dec 2013 New trial record